prof. dr. An De Vriese

Journal Article
A1
open access

Clinicopathological characteristics and disease chronicity in native kidney biopsies in Flanders

Dries Deleersnijder, Wim Laurens (UGent) , Johan De Meester, Evert Cleenders, Amélie Dendooven (UGent) , Evelyne Lerut, An De Vriese (UGent) , Tom Dejagere, Mark Helbert, Rachel Hellemans, et al.

(2023) CLINICAL KIDNEY JOURNAL. 16(1). p.125-137

Add to list

Journal Article
A1
open access

Immune senescence markers predict the cellular immune response to BNT162b2 vaccination in hemodialysis patients

Jens Van Praet (UGent) , Marie De Groote, Dirk De Bacquer (UGent) , Ellen Verhalleman, Ziggy Welvaert, Jan Emmerechts, Marijke Reynders and An De Vriese (UGent)

(2022) OPEN FORUM INFECTIOUS DISEASES. 9(11).

Add to list

Journal Article
A1
open access

Longevity and clinical effectiveness of the humoral and cellular responses to SARS-CoV-2 vaccination in hemodialysis patients

An De Vriese (UGent) , Jens Van Praet (UGent) , Marijke Reynders, Line Heylen, Liesbeth Viaene, Rogier Caluwé, Melanie Schoutteten and Dirk De Bacquer (UGent)

(2022) KIDNEY INTERNATIONAL REPORTS. 7(7). p.1103-1107

Add to list

Journal Article
A1
open access

Epidemiology of native kidney disease in Flanders : results from the FCGG kidney biopsy registry

Wim Laurens (UGent) , Dries Deleersnijder, Amélie Dendooven (UGent) , Evelyne Lerut, An De Vriese (UGent) , Tom Dejagere, Mark Helbert, Rachel Hellemans, Priyanka Koshy, Bart Maes (UGent) , et al.

(2022) CLINICAL KIDNEY JOURNAL. 15(7). p.1361-1372

Add to list

Journal Article
A1
open access

Longevity and correlation with disease severity of the humoral and cellular response to SARS-CoV-2 infection in haemodialysis patients

An De Vriese (UGent) , Jens Van Praet (UGent) , Marijke Reynders, Line Heylen, Liesbeth Viaene, Rogier Caluwé, Melanie Schoutteten and Dirk De Bacquer (UGent)

(2021) CLINICAL KIDNEY JOURNAL. 14(11). p.2446-2448

Add to list

Dynamics of the cellular and humoral immune response after BNT162b2 mRNA Covid-19 vaccination in Covid-19 naive nursing home residents

Jens Van Praet (UGent) , Stefaan Vandecasteele, Anneleen De Roo, Matthijs Vynck (UGent) , An De Vriese (UGent) and Marijke Reynders

(2021) JOURNAL OF INFECTIOUS DISEASES. 224(10). p.1690-1693

Add to list

Predictors and dynamics of the humoral and cellular immune response to SARS-CoV-2 mRNA vaccines in hemodialysis patients : a multicenter observational study

Jens Van Praet (UGent) , Marijke Reynders, Dirk De Bacquer (UGent) , Liesbeth Viaene, Melanie Schoutteten, Rogier Caluwé, Peter Doubel, Line Heylen, Annelies De Bel, Deborah Steensels, et al.

(2021) JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 32(12). p.3208-3220

Add to list

Humoral and cellular immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in nursing home residents

Jens Van Praet (UGent) , Stefaan Vandecasteele, Anneleen De Roo, An De Vriese (UGent) and Marijke Reynders

(2021) CLINICAL INFECTIOUS DISEASES. 73(11). p.2145-2147

Add to list

Incidence, characteristics, and outcome of COVID-19 in adults on kidney replacement therapy : a regionwide registry study

Johan De Meester, Dirk De Bacquer (UGent) , Maarten Naessens, Bjorn Meijers, Marie M. Couttenye, An De Vriese (UGent) , Wim Van Biesen (UGent) and [ missing ] on behalf of NBVN Kidney Registry Group

(2021) JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 32(2). p.385-396

Add to list

Multicenter randomized controlled trial of vitamin K antagonist replacement by rivaroxaban with or without vitamin K2 in hemodialysis patients with atrial fibrillation : the Valkyrie study

An De Vriese (UGent) , Rogier Caluwé, Lotte Pyfferoen, Dirk De Bacquer (UGent) , Koen De Boeck, Joost Delanote, Didier De Surgeloose, Piet Vanhoenacker (UGent) , Bruno Van Vlem and Francis Verbeke (UGent)

(2020) JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 31(1). p.186-196

Academic Bibliography

prof. dr. An De Vriese

Clinicopathological characteristics and disease chronicity in native kidney biopsies in Flanders

Immune senescence markers predict the cellular immune response to BNT162b2 vaccination in hemodialysis patients

Longevity and clinical effectiveness of the humoral and cellular responses to SARS-CoV-2 vaccination in hemodialysis patients

Epidemiology of native kidney disease in Flanders : results from the FCGG kidney biopsy registry

Longevity and correlation with disease severity of the humoral and cellular response to SARS-CoV-2 infection in haemodialysis patients

Dynamics of the cellular and humoral immune response after BNT162b2 mRNA Covid-19 vaccination in Covid-19 naive nursing home residents

Predictors and dynamics of the humoral and cellular immune response to SARS-CoV-2 mRNA vaccines in hemodialysis patients : a multicenter observational study

Humoral and cellular immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in nursing home residents

Incidence, characteristics, and outcome of COVID-19 in adults on kidney replacement therapy : a regionwide registry study

Multicenter randomized controlled trial of vitamin K antagonist replacement by rivaroxaban with or without vitamin K2 in hemodialysis patients with atrial fibrillation : the Valkyrie study

Contents

Support

Contact